112.26
前日終値:
$112.15
開ける:
$112.08
24時間の取引高:
1.05M
Relative Volume:
0.62
時価総額:
$22.86B
収益:
$7.60B
当期純損益:
$1.08B
株価収益率:
21.34
EPS:
5.26
ネットキャッシュフロー:
$1.26B
1週間 パフォーマンス:
+1.38%
1か月 パフォーマンス:
+7.89%
6か月 パフォーマンス:
+3.73%
1年 パフォーマンス:
-14.94%
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
名前
Zimmer Biomet Holdings Inc
セクター
電話
(574) 267-6131
住所
345 EAST MAIN STREET, WARSAW, IN
ZBH を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
ZBH
Zimmer Biomet Holdings Inc
|
112.26 | 22.86B | 7.60B | 1.08B | 1.26B | 5.26 |
![]()
ABT
Abbott Laboratories
|
130.82 | 226.88B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
99.36 | 146.96B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
364.50 | 142.81B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
87.63 | 112.37B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
70.91 | 41.85B | 5.72B | 4.17B | 259.90M | 6.97 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-12-17 | アップグレード | JP Morgan | Neutral → Overweight |
2024-09-10 | 開始されました | Wolfe Research | Peer Perform |
2024-07-01 | ダウングレード | Piper Sandler | Overweight → Neutral |
2024-05-30 | 開始されました | Goldman | Neutral |
2024-05-21 | アップグレード | Argus | Hold → Buy |
2024-01-04 | ダウングレード | Evercore ISI | Outperform → In-line |
2023-10-20 | 開始されました | ROTH MKM | Neutral |
2023-08-28 | アップグレード | BTIG Research | Neutral → Buy |
2023-05-03 | アップグレード | BofA Securities | Underperform → Neutral |
2023-04-11 | アップグレード | Evercore ISI | In-line → Outperform |
2023-03-31 | アップグレード | Jefferies | Underperform → Hold |
2023-03-29 | 開始されました | UBS | Sell |
2023-03-10 | アップグレード | Piper Sandler | Neutral → Overweight |
2023-01-09 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
2023-01-05 | アップグレード | Raymond James | Mkt Perform → Outperform |
2023-01-03 | ダウングレード | Evercore ISI | Outperform → In-line |
2022-11-23 | アップグレード | Wells Fargo | Underweight → Equal Weight |
2022-10-18 | 開始されました | Barclays | Underweight |
2022-10-12 | 開始されました | Jefferies | Underperform |
2022-05-27 | ダウングレード | Needham | Buy → Hold |
2022-04-13 | ダウングレード | Truist | Buy → Hold |
2022-04-01 | ダウングレード | Citigroup | Buy → Neutral |
2022-03-02 | 再開されました | BofA Securities | Underperform |
2022-03-02 | ダウングレード | Loop Capital | Buy → Hold |
2022-02-08 | ダウングレード | Canaccord Genuity | Buy → Hold |
2022-02-08 | 繰り返されました | Citigroup | Buy |
2022-02-08 | 繰り返されました | Deutsche Bank | Hold |
2022-02-08 | 繰り返されました | JMP Securities | Mkt Outperform |
2022-02-08 | 繰り返されました | JP Morgan | Neutral |
2022-02-08 | 繰り返されました | RBC Capital Mkts | Sector Perform |
2022-02-08 | 繰り返されました | Stifel | Buy |
2022-02-08 | 繰り返されました | Truist | Buy |
2022-02-08 | 繰り返されました | UBS | Neutral |
2022-02-08 | 繰り返されました | Wells Fargo | Underweight |
2022-02-02 | ダウングレード | UBS | Buy → Neutral |
2022-01-19 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
2022-01-10 | ダウングレード | Mizuho | Buy → Neutral |
2022-01-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2022-01-04 | ダウングレード | Piper Sandler | Overweight → Neutral |
2021-12-10 | 開始されました | RBC Capital Mkts | Sector Perform |
2021-12-09 | ダウングレード | Needham | Strong Buy → Buy |
2021-12-07 | 開始されました | Loop Capital | Buy |
2021-11-23 | ダウングレード | Argus | Buy → Hold |
2021-09-14 | 再開されました | Raymond James | Mkt Perform |
2021-05-25 | 開始されました | Barclays | Overweight |
2021-04-09 | アップグレード | Northland Capital | Market Perform → Outperform |
2021-01-04 | アップグレード | Evercore ISI | In-line → Outperform |
2020-12-18 | 繰り返されました | Needham | Strong Buy |
2020-10-20 | 開始されました | Northland Capital | Market Perform |
2020-09-11 | 開始されました | Wolfe Research | Outperform |
2020-08-05 | 繰り返されました | Needham | Strong Buy |
2020-04-28 | ダウングレード | Guggenheim | Buy → Neutral |
2020-04-09 | ダウングレード | Evercore ISI | Outperform → In-line |
2020-04-07 | 繰り返されました | Needham | Strong Buy |
2020-03-05 | 開始されました | Citigroup | Buy |
2020-02-13 | 開始されました | Goldman | Buy |
2020-01-08 | 開始されました | SunTrust | Buy |
2020-01-07 | アップグレード | Piper Jaffray | Neutral → Overweight |
2020-01-07 | アップグレード | Piper Sandler | Neutral → Overweight |
2019-12-04 | アップグレード | Raymond James | Outperform → Strong Buy |
2019-10-07 | アップグレード | BTIG Research | Neutral → Buy |
2019-09-18 | アップグレード | Canaccord Genuity | Hold → Buy |
2019-08-12 | アップグレード | Argus | Hold → Buy |
2019-07-30 | アップグレード | Barclays | Underweight → Equal Weight |
2019-07-29 | アップグレード | Robert W. Baird | Neutral → Outperform |
2019-06-11 | アップグレード | Bernstein | Underperform → Mkt Perform |
2019-04-24 | アップグレード | Needham | Buy → Strong Buy |
すべてを表示
Zimmer Biomet Holdings Inc (ZBH) 最新ニュース
Just Three Days Till Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Will Be Trading Ex-Dividend - Simply Wall St
Ex-Dividend Reminder: PG&E, Zimmer Biomet Holdings and Ensign Group - Nasdaq
Goldman Sachs Adjusts PT on Zimmer Biomet Holdings to $120 From $115, Maintains Neutral Rating - Marketscreener.com
Looking Into Zimmer Biomet Holdings's Recent Short Interest - Benzinga
3 Promising Surgical Robotics Stocks to Keep an Eye on in 2025 - TradingView
Zimmer Holdings Q3 profit surges, cuts FY08 outlookupdate - RTTNews
Europe Viscosupplementation Market Set to Witness Significant - openPR
Is Zimmer Biomet Stock Outperforming the S&P 500? - Inkl
Reflecting On Surgical Equipment & ConsumablesDiversified Stocks’ Q4 Earnings: Zimmer Biomet (NYSE:ZBH) - Yahoo Finance
Spinal Fusion Device Market Forecast Report and Company Analysis 2025-2033 Featuring Medtronic, Stryker, Zimmer Biomet, Orthofix Medical, NuVasive, Globus Medical, Xtant Medical, and Alphatec – Ortho Spine News - OrthoSpineNews
Spinal Fusion Device Market Forecast Report and Company - GlobeNewswire
Zimmer Biomet Holdings (NYSE:ZBH) Has Announced A Dividend Of $0.24 - Simply Wall St
Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24 - Yahoo Finance
Zimmer Biomet Focuses on Innovation Amid Growing Competition - Yahoo Finance
Zimmer Biomet at Barclays Conference: Strategic Growth Insights By Investing.com - Investing.com South Africa
Proficio Capital Partners LLC Takes $55,000 Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - Defense World
Rep. Julie Johnson Sells Off Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - Defense World
Zimmer Biomet at Barclays Conference: Strategic Growth Insights - Investing.com
Zimmer Q3 Sales Disappoint, Trims FY10 Sales Growth ForecastUpdate - RTTNews
Q3 EPS Estimates for Zimmer Biomet Lowered by Zacks Research - Defense World
Zimmer Biomet Focusing On Innovation Pipeline And Product Portfolio To Drive Growth - RTTNews
ZBH Stock to Gain From Global Expansion Amid Difficult FX Scenario - TradingView
Zimmer Biomet Holdings: Balancing Optimism with Caution Amid Strategic Growth and Market Challenges - TipRanks
Zimmer Biomet Holdings: Strategic Initiatives and Execution Risks Justify Hold Rating - TipRanks
Zimmer Biomet Q1 EPS Forecast Reduced by Zacks Research - Defense World
Paragon 28 clears regulatory hurdle in Zimmer Biomet merger By Investing.com - Investing.com Australia
Paragon 28 clears regulatory hurdle in Zimmer Biomet merger - Investing.com India
Paragon 28 Announces Expiration of HSR Act Waiting Period for Pending Acquisition by Zimmer Biomet Under HSR Act - Joplin Globe
Paragon 28 Acquisition by Zimmer Biomet Clears Major Regulatory Hurdle - StockTitan
Tissue Engineering Market Analysis, Competitive Intelligence, and Growth Opportunities to 2030Zimmer Biomet, Stryker Corporation, and 3D BioFibR Lead the Industry - GlobeNewswire
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Stock Holdings Lowered by Steward Partners Investment Advisory LLC - Defense World
Zimmer Biomet Highlights Diverse Portfolio of Orthopedic & Musculoskeletal Innovations at AAOS 2025 Annual Meeting - PR Newswire
Zimmer Biomet Holdings, Inc. to Host Earnings Call - ACCESS Newswire
Mutual of America Capital Management LLC Decreases Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - Defense World
Zimmer Biomet SVP Lori Winkler sells $150,649 in stock By Investing.com - Investing.com Canada
Top Executive Cashes In on Zimmer Biomet Holdings Stock - TipRanks
Zimmer Biomet to Present at the 27th Annual Barclays Healthcare Conference - GuruFocus.com
Zimmer Biomet SVP Lori Winkler sells $150,649 in stock - Investing.com
There May Be Some Bright Spots In Zimmer Biomet Holdings' (NYSE:ZBH) Earnings - Yahoo Finance
FDA clears revision knee implant from Zimmer Biomet - Mass Device
Zimmer Biomet Says Tivanium Knee Implant Component Receives US FDA Clearance - Marketscreener.com
Zimmer Biomet Receives FDA Clearance For Persona® Revision Solution(TM) Femur -March 07, 2025 at 08:03 am EST - Marketscreener.com
Zimmer Biomet Receives FDA Clearance for Persona® Revision SoluTion™ Femur - GuruFocus.com
Dental Implant Market Forecast Report and Company Analysis 2025-2033 Featuring Danaher, Dentsply Sirona, Institut Straumann, Zimmer Biomet, Kyocera, Henry Schein, Biocon, and Osstem implant - Yahoo Finance UK
Zimmer Biomet Holdings (NYSE:ZBH) Appoints Kristen Cardillo As Chief Communications Officer - Yahoo Finance
Zimmer Biomet Names Kristen Cardillo as Senior Vice President, C - GuruFocus.com
Zimmer Biomet Names Kristen Cardillo As Senior Vice President, Chief Communications Officer - Marketscreener.com
Zimmer Biomet Names Kristen Cardillo as Senior Vice President, Chief Communications Officer - PR Newswire
Strategic Move: Healthcare Giant Zimmer Biomet Taps Communications Veteran from 10x Genomics - StockTitan
Zimmer Biomet Holdings, Inc. (ZBH): A Bull Case Theory - MSN
Zimmer Biomet Holdings Inc (ZBH) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):